The recent uptick in venture capital investments in the biotechnology sector and the increasing number of partnerships between large and smaller biotech firms should help drugmakers replenish their pipeline and come up with better products in the future. Data from a Moneytree report showed that the biotech industry secured more than $4 billion in venture capital investments last year, an 8% growth, making it the second-biggest investment sector for venture capitalists for the year.
Surge in VC funding, dealmaking will improve biotech drug pipeline
SmartBrief Job Listings for Health Care
|Vice President - Government Products||
Health Alliance Plan
|Director, Compliance - Health Plan Privacy & Security||
|Chief Medical Officer||
VANDERBILT HEALTH AFFILIATE NETWORK
|Commercial Health Insurance Strategist__Job #52-14||
American Academy of Family Physicians
|Manager of Payer Relations||
Pharmacy Quality Solutions, Inc.